Belongs to

• Solid Tumor Oncology Division

Types of Work

["2020"]

[[["Journal Articles",802],["Meeting Abstracts",555],["Book Sections",38],["Reviews",13],["Editorials",9],["Guidelines",8],["Books Whole",1],["Correspondences",1],["Miscellaneous",1]]]

[1428]

Popular keywords

• adult
• aged
• article
• cancer survival
• clinical trial
• female
• human
• middle aged
• paclitaxel
• priority journal

Recent Works

1. Phase 2 study of zenocutuzumab (MCLA-128), a bispecific HER2/HER3 antibody in NRG1 fusion-positive advanced solid tumors

   Meeting Abstract

   Schram, A.; Macarulla, T.; O'Reilly, E.; Rodon, J.; Wolpin, B.; Ou, S.; Kim, D.; Yang, J. C.; Lam, J.; De Langen, A.; more...
   Journal of Thoracic Oncology (2021)

   Fulltext@MSK | Save
2. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma

   Journal Article

   Momeni-Boroujeni, A.; Mohammad, N.; Wolber, R.; Yip, S.; Köbel, M.; Dickson, B. C.; Hensley, M. L.; Leitao, M. M. Jr; Antonescu, C. R.; Benayed, R.; more...
   Modern Pathology (2021)

   Fulltext@MSK | Save
3. Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): A randomised, phase 3 trial

   Journal Article

   Friedlander, M.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; more...
   Lancet Oncology (2021)

   Fulltext@MSK | Save